Nexalin Technology Equity Warrants Exp 15th Sept 2025 NXLIW:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/27/22 EDT
0.188UNCH (UNCH)
Volume
111
52 week range
0.17 - 0.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.188
  • 52 Week High0.40
  • 52 Week High Date09/16/22
  • 52 Week Low0.17
  • 52 Week Low Date09/19/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.188
  • 52 Week High0.40
  • 52 Week High Date09/16/22
  • 52 Week Low0.17
  • 52 Week Low Date09/19/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nexalin Technology Equity Warrants Exp 15th Sept 2025

 

Profile

MORE
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for mental health epidemic. The Company developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. It is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to...
Address
26072 MERIT CIRCLE, SUITE 106
Laguna Niguel, CA
92653
United States